Nursing Symposium Overview
The 4th Nursing Symposium will be held on Friday, September 13, 2019, in conjunction with the 17th International Myeloma Workshop in Boston, Massachusetts. The audience for this live conference is nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists, and physicians. In particular, the educational symposia will include didactic, interactive, evidence-based, and fair-balanced content targeted to the supportive care of the patient with multiple myeloma. A particular focus will be placed in the role of immunotherapies, unique considerations with the delivery of new drugs and management of side effects, and the use of patient reported outcomes in our understanding of quality of life. There will be a variety of educational formats conducive to interaction and includes live oral presentations with Q&A sessions. Nurses will be able to disseminate the latest nursing research in the field of myeloma with the best-selected abstracts presented live in a plenary session and also in poster format within the main program.
Abstract Submission to the Nursing Symposium
The Nursing Scientific Program Committee invites you to submit an abstract for the 17th International Myeloma Workshop, taking place September 12-15, 2019 in Boston, Massachusetts.
Any licensed healthcare professional can submit an abstract to be considered for oral or poster presentation in the nursing conference to be held on September 13, 2019. Ten oral abstracts will be selected. Abstracts selected (oral and poster) will be included in official conference proceedings.
Abstracts are being considered in areas relating broadly, to supportive care in myeloma. This may include symptom management; toxicities; health related quality of life (HRQOL); late and long-term effects; models of care; advanced practice nursing and care delivery.
For the submitted abstract, please include:
- All authors and Affiliation/Institution
- Corresponding Author/Email
- Abstract (It is suggested that the abstract be structured as below):
- Background:
- Aims:
- Methods:
- Results:
- Conclusion
- Conflict of Interest Disclosure for each author
Submission Types
Oral Abstract – Ten high-ranking abstracts will be selected for oral presentation.
Poster Abstract – Presenters will make physical or electronic posters to present during dedicated poster sessions. Presenters are required to be with their posters during the evening poster reception times.
Guidelines for submission
- All abstract submissions must be submitted online. The Scientific Program Committee will not accept faxed, emailed or mailed submissions.
- Authors must indicate that they would like to be considered for the Nursing Symposium before submitting their abstract.
- Authors may make changes to the abstract until the submission deadline. No changes will be accepted after the submission deadline.
- All accepted abstract presenters must be registered for the IMW prior to presentation.
- The IMW does not cover travel or registration fees for abstract presenters.
- All complete and finalized abstracts will be reviewed by the Scientific Program Committee.
Submit your abstract here. The deadline for abstract submissions is Wednesday, June 19, 2019 at 11:59 p.m. ET. Notifications will be made by Friday, June 28, 2019.
Abstracts for research with late breaking results will be considered until Wednesday, July 24, with notifications by Thursday, August 1, 2019.
SUBMIT AN ABSTRACT
Registration
Nursing Symposium and Workshop Access |
Guest | |
Nursing Symposium | $200 | $300* |
*Guests are welcome to register for the IMW. Guests will receive a badge that allows access to the exhibition area including coffee breaks and lunch, and the Opening and Closing Ceremony Events. This registration rate does not include entrance to scientific sessions and does not include meeting materials. |
REGISTER NOW
CME Credits
2019 Nursing Symposium Organizing Committee
Co-Chair
Australia: Tracy King RN MSc
Clinical Nurse Consultant, Multiple Myeloma, Royal Prince Alfred Hospital, Sydney
Clinical Lecturer & Research Fellow, Sydney University, Sydney
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Co-Chair
USA: Beth Faiman PhD, MSN, APRN-BC, AOCN
Nurse Practitioner, Multiple Myeloma Program, Cleveland Clinic Ohio
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Co-Chair
USA: Kathy Colson RN, BSN, BS
Clinical Research Nurse, Multiple Myeloma
Department of Hematology Oncology
Dana-Farber Cancer Institute, Boston
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Co-Chair
USA: Kimberly Noonan RN, ANP, AOCN
Dana-Farber Cancer Institute, Boston
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
USA: Deborah Doss RN, OCN
Dana-Farber Cancer Institute, Boston
USA: Jill Burke APRN BC
Nurse Practitioner, Multiple Myeloma, Plasma Cell Diseases
Massachusetts General Hospital, Boston
Center for Multiple Myeloma
USA: Charise Gleason, MSN, NP-BC, AOCNP
Nurse Practitioner, Multiple Myeloma Program
The Winship Cancer Institute of Emory University, Atlanta, GA
USA: Tiffany Richards MS, ANP-BC
Nurse Practitioner, Multiple Myeloma
MD Anderson, Houston
INTERNATIONAL AFFILIATES
Australia: Julija Sipavicius
BMT / Multiple Myeloma Nurse Practitioner
Royal North Shore Hospital, Sydney
Switzerland: Matthias Hellberg-Naegele
Advanced Practice Nurse Multiple Myeloma
Cancer Center, Zurich
UK: Tanya Burton
MacMillan Myeloma Clinical Nurse Specialist
Cardiff & Vale Health Board, Wales
UK: Emma Dowling London
MacMillan Myeloma Clinical Nurse Specialist
HCA Healthcare UK @UCH, London
Questions? Contact us.
IMW Abstract Management
c/o SPARGO, Inc.
11208 Waples Mill Road
Suite 112
Fairfax, VA 22030 USA
888-788-1522 (US Toll free)
001 703-679-3907 (International)
This email address is being protected from spambots. You need JavaScript enabled to view it.